Stay updated on Amgen Press Releases

Sign up to get notified when there's something new on the Amgen Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Amgen Press Releases page

  1. Check
    4 days ago
    Change Detected
    Summary
    The webpage has been updated with several important announcements from Amgen, including a webcast for financial results and FDA approval for a new cancer treatment.
    Difference
    100%
    Check dated 2025-07-11T07:10:37.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    No Change Detected
  6. Check
    54 days ago
    Change Detected
    Summary
    The webpage has removed specific future dates and events related to Amgen, including a conference presentation and financial results report.
    Difference
    100%
    Check dated 2025-05-22T02:25:35.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The webpage has added significant updates regarding Amgen's upcoming presentations and financial results for the first quarter of 2025.
    Difference
    100%
    Check dated 2025-05-14T21:14:55.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The webpage has removed several significant updates regarding FDA approvals and clinical trial results for various treatments, including UPLIZNA® and LUMAKRAS®, which are crucial for understanding current treatment options and advancements in healthcare.
    Difference
    100%
    Check dated 2025-04-30T13:58:57.000Z thumbnail image
  9. Check
    90 days ago
    Change Detected
    Summary
    The page now includes a significant addition regarding the IMDELLTRA® treatment, highlighting its demonstrated superior overall survival in small cell lung cancer as of April 11, 2025.
    Difference
    69%
    Check dated 2025-04-16T05:28:26.000Z thumbnail image
  10. Check
    97 days ago
    Change Detected
    Summary
    The webpage now includes significant updates regarding FDA approvals and clinical trial results for various treatments, including UPLIZNA® as the first FDA-approved treatment for IgG4-related disease and new data on its efficacy for generalized myasthenia gravis. Additionally, there are announcements of upcoming presentations and financial results from Amgen.
    Difference
    100%
    Check dated 2025-04-09T01:45:02.000Z thumbnail image

Stay in the know with updates to Amgen Press Releases

Enter your email address, and we'll notify you when there's something new on the Amgen Press Releases page.